BRICS Cancer Targeted Therapy Market Report Outlook (2021–2031)
The BRICS Cancer Targeted Therapy Market size is expected to reach US$ 39,876.2 million by 2031 from US$ 14,697.6 million in 2024. The market is estimated to record a CAGR of 15.3% from 2025 to 2031.
Report Coverage
- Therapy Type: Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Immune Checkpoint Inhibitors, Cancer Vaccines, Gene Therapy, Other Therapy Types
- Indication: Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
- End User: Hospital Pharmacies, Retail Pharmacies, Online Stores
US$ 14,697.6 Mn
Market size in 2024
US$ 39,876.2 Mn
Market Size by 2031
15.3%
CAGR, 2025 - 2031
2025-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. BRICS Cancer Targeted Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. BRICS Cancer Targeted Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. BRICS Cancer Targeted Therapy Market Regional Analysis
6.2 BRICS Cancer Targeted Therapy Market Revenue 2021-2031 (US$ Million)
6.3 BRICS Cancer Targeted Therapy Market Forecast Analysis
7. BRICS Cancer Targeted Therapy Market Analysis – by Therapy Type
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Tyrosine Kinase Inhibitors
- 7.2.1 Overview
- 7.2.2 Tyrosine Kinase Inhibitors: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Immune Checkpoint Inhibitors
- 7.3.1 Overview
- 7.3.2 Immune Checkpoint Inhibitors: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Cancer Vaccines
- 7.4.1 Overview
- 7.4.2 Cancer Vaccines: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Gene Therapy
- 7.5.1 Overview
- 7.5.2 Gene Therapy: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Types
- 7.6.1 Overview
- 7.6.2 Other Therapy Types: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. BRICS Cancer Targeted Therapy Market Analysis – by Indication
8.1 Blood Cancer
- 8.1.1 Overview
- 8.1.2 Blood Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Lung Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
- 8.3.1 Overview
- 8.3.2 Breast Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
- 8.4.1 Overview
- 8.4.2 Colorectum Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
- 8.5.1 Overview
- 8.5.2 Prostate Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
- 8.6.1 Overview
- 8.6.2 Stomach Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
- 8.7.1 Overview
- 8.7.2 Cervical Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
- 8.8.1 Overview
- 8.8.2 Liver and Intrahepatic Bile Duct Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
- 8.9.1 Overview
- 8.9.2 Thyroid Cancer: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
- 8.10.1 Overview
- 8.10.2 Other Indications: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. BRICS Cancer Targeted Therapy Market Analysis – by End User
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
- 9.3.1 Overview
- 9.3.2 Online Stores: BRICS Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. BRICS Cancer Targeted Therapy Market – BRICS Analysis
10.1 Overview
10.2 BRICS- 10.2.1 BRICS Cancer Targeted Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
- 10.2.1.1 BRICS Cancer Targeted Therapy Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Russia: BRICS Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Russia: BRICS Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.1.2 Russia: BRICS Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.1.3 Russia: BRICS Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.2 Brazil: BRICS Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Brazil: BRICS Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.2.2 Brazil: BRICS Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.2.3 Brazil: BRICS Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.3 South Africa: BRICS Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 South Africa: BRICS Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.3.2 South Africa: BRICS Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.3.3 South Africa: BRICS Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.4 India: BRICS Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 India: BRICS Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.4.2 India: BRICS Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.4.3 India: BRICS Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.5 UAE: BRICS Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 UAE: BRICS Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.5.2 UAE: BRICS Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.5.3 UAE: BRICS Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.6 China: BRICS Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 China: BRICS Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.6.2 China: BRICS Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.6.3 China: BRICS Cancer Targeted Therapy Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Astellas Pharma Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Eli Lilly and Co
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Novartis AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Merck KGaA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Johnson & Johnson
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 AstraZeneca
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Pfizer Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Bristol Myers Squibb
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 F. Hoffmann-La Roche Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 AbbVie
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full BRICS Cancer Targeted Therapy Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.